TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18362294

Group type: EXPERIMENTAL
Intervention: Desmopressin (3 mug)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (i.v. saline)
Number of subjects: 14
Study: 17027729

Group type: EXPERIMENTAL
Intervention: Carotid-artery stenting (n=605)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Carotid endarterectomy (n=595)
Number of subjects: 1200
Study: 12802619

Group type: EXPERIMENTAL
Intervention: high trans‐scrotal skin‐crease incision
Number of subjects: 256

Group type: COMPARATOR
Intervention: suprapubic transverse inguinal incisions
Number of subjects: 256
Study: 10753980

Group type: EXPERIMENTAL
Intervention: rtPA (alteplase) 0.9 mg/kg IV over 1 hour
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 7796857

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2162437

Group type: EXPERIMENTAL
Intervention: COMP (cyclophosphamide, vincristine, methotrexate, procarbazine)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Cyclic alternating chemotherapy (CT) of COMP and VAN (etoposide, adriamycin, nimustine)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: CT plus RT of 40 Gy
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: CAV-PVP hybrid chemotherapy (CTX, ADM, VCR on day 1; cisplatin on day 8; VP-16 on days 8 and 9)
Number of subjects: 183
Study: 396651

Group type: EXPERIMENTAL
Intervention: Pirenzepine (25 mg three times per day for 1 week followed by 25 mg two times per day for 3 weeks)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 84
Study: 31511288

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 170

Group type: COMPARATOR
Intervention: Abiraterone plus prednisolone (AAP)
Number of subjects: 170
Study: 27906770

Group type: EXPERIMENTAL
Intervention: Training in a simple classification for proximal humeral fractures
Number of subjects: 185

Group type: COMPARATOR
Intervention: No training in a simple classification for proximal humeral fractures
Number of subjects: 185
Study: 26255794

Group type: EXPERIMENTAL
Intervention: High BX diet
Number of subjects: 19

Group type: COMPARATOR
Intervention: Low BX diet
Number of subjects: 19
Study: 23073216

Group type: EXPERIMENTAL
Intervention: Single exercise bout (brisk walking at 60% of peak oxygen consumption for 123 ± 18 min, net energy expenditure of 2.06 ± 0.39 MJ, ∼500 kcal)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dietary energy restriction of 2.10 ± 0.41 MJ
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control day of isocaloric feeding and rest (zero energy balance)
Number of subjects: 11
Study: 21299475

Group type: EXPERIMENTAL
Intervention: Zileuton 600 mg orally, 4 times daily for 14 days
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Zileuton
Number of subjects: 119
Study: 18564334

Group type: EXPERIMENTAL
Intervention: Carvedilol (6.25-25 mg twice daily)
Number of subjects: 1235

Group type: COMPARATOR
Intervention: Metoprolol tartrate (50-200 mg twice daily)
Number of subjects: 1235
Study: 16820580

Group type: EXPERIMENTAL
Intervention: GIK (40% dextrose, K+ 100 mmol.L(‐1), insulin 70 u.L(‐1)) administered at 0.75 mL.kg(‐1) h(‐1) from start of operation until 6 hours after removal of aortic cross-clamp (AXC)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: T3 (0.8 microg.kg(‐1) followed by 0.113 microg.kg(‐1) h(‐1)) administered for a 6-hour period from removal of AXC
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: GIK+T3
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 440
Study: 12603364

Group type: EXPERIMENTAL
Intervention: Patients with suspected sleep apnoea syndrome (n = 421)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Patients with confirmed obstructive sleep apnoea syndrome
Number of subjects: 421

Group type: COMPARATOR
Intervention: General population (n = 41,340)
Number of subjects: 421
Study: 10839875

Group type: EXPERIMENTAL
Intervention: LED phototherapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional phototherapy
Number of subjects: 69
Study: 9103126

Group type: EXPERIMENTAL
Intervention: PBSC transplantation
Number of subjects: 129

Group type: COMPARATOR
Intervention: Bone marrow transplantation
Number of subjects: 129
Study: 8488694

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 0
Study: 2442417

Group type: EXPERIMENTAL
Intervention: Sodium pentosanpolysulfate (Elmiron) 100 mg, 3 times daily for a minimum of 4 months
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sodium pentosanpolysulfate (Elmiron)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 62
Study: 30250631

Group type: EXPERIMENTAL
Intervention: Nonvalved Spacers (NVS)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Valved Holding Chambers (VHC)
Number of subjects: 46
Study: 27550746

Group type: EXPERIMENTAL
Intervention: Adaptive attention training condition
Number of subjects: 76

Group type: COMPARATOR
Intervention: Nonadaptive control condition
Number of subjects: 76
Study: 26666981

Group type: EXPERIMENTAL
Intervention: iCup (disposable vacuum extraction cup)
Number of subjects: 668

Group type: COMPARATOR
Intervention: Drapier-Faure metallic cup (control)
Number of subjects: 668
Study: 23129412

Group type: EXPERIMENTAL
Intervention: Idebenone (450 mg/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 21
Study: 20118767

Group type: EXPERIMENTAL
Intervention: M. vaccae
Number of subjects: 2013

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2013
Study: 18817987

Group type: EXPERIMENTAL
Intervention: sulphurous thermal water inhalations
Number of subjects: 100

Group type: COMPARATOR
Intervention: physiological solution
Number of subjects: 100
Study: 17058823

Group type: EXPERIMENTAL
Intervention: Shenfu Injection before CPB
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Shenfu Injection after CPB
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no Shenfu Injection)
Number of subjects: 90
Study: 12730149

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of saline for 20 minutes
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of saline
Number of subjects: 7
Study: 10391422

Group type: EXPERIMENTAL
Intervention: oral microemulsion CsA 5 mg/kg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: intravenous CsA 1.5 mg/kg
Number of subjects: 11
Study: 8871363

Group type: EXPERIMENTAL
Intervention: Video feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: No video feedback (control)
Number of subjects: 0
Study: 1642943

Group type: COMPARATOR
Intervention: No supplementary oxygen before LMA placement
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Manual ventilation with 100% oxygen after induction
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Partial denitrogenation by breathing oxygen from the start of injection of the induction agent
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Formal denitrogenation by breathing oxygen for 3 min
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Five tidal volume breaths of oxygen by face mask using positive pressure immediately after induction
Number of subjects: 87
Study: 6377970

Group type: EXPERIMENTAL
Intervention: Kallikrein 600 K.U. daily for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 30
Study: 30917531

Group type: EXPERIMENTAL
Intervention: Vitamin D3 100,000 IU soft capsule (Group 1)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Vitamin D3 100,000 IU oral solution in ampoule (Group 2)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 53
Study: 28419661

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Non‐directive supportive counselling (NDC)
Number of subjects: 85
Study: 26485251

Group type: EXPERIMENTAL
Intervention: Standardized communication techniques
Number of subjects: 13

Group type: COMPARATOR
Intervention: Nonstandard communication
Number of subjects: 13
Study: 24806873

Group type: EXPERIMENTAL
Intervention: Stepwise Protocol of Treating Pain (individual daily pain treatment with paracetamol, extended release morphine, buprenorphine transdermal patch or pregabaline for 8 weeks)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Stepwise Protocol of Treating Pain
Number of subjects: 352

Group type: COMPARATOR
Intervention: Usual treatment (control group)
Number of subjects: 352
Study: 22027909

Group type: EXPERIMENTAL
Intervention: FDG-PET/CT
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Follow-up (FDG-PET/CT)
Number of subjects: 10
Study: 19050388

Group type: EXPERIMENTAL
Intervention: Drug conservation (episodic use of antiretroviral therapy guided by CD4 cell count)
Number of subjects: 499

Group type: COMPARATOR
Intervention: Viral suppression (continuous antiretroviral therapy)
Number of subjects: 499
Study: 17608870

Group type: EXPERIMENTAL
Intervention: In-home palliative care
Number of subjects: 298
Study: 14872248

Group type: EXPERIMENTAL
Intervention: Integrated system (Yoko 232 grip and Yoko 232 strap)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Modern system (Swix PC grip and SR94 strap)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Traditional system (Swix PC grip and simple strap)
Number of subjects: 11
Study: 12241778

Group type: EXPERIMENTAL
Intervention: Deltamethrin-impregnated dog collars
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Control (no collars)
Number of subjects: 1141
Study: 9432075

Group type: EXPERIMENTAL
Intervention: Oral acetaminophen
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Acetaminophen with codeine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 8207744

Group type: EXPERIMENTAL
Intervention: Verapamil 360 mg per day
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 2686457

Group type: EXPERIMENTAL
Intervention: NET (A) (Ortho‐Novum 7/7/7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NET (B) (Tri‐Norinyl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LNG (Tri‐Levlen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30794284

Group type: EXPERIMENTAL
Intervention: 4-week postoperative rehabilitation program in Nursing Care Facilities (NCFs)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study: 27432436

Group type: EXPERIMENTAL
Intervention: Inactivated FVRCP vaccine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modified live FVRCP vaccine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (unvaccinated)
Number of subjects: 24
Study: 24893681

Group type: EXPERIMENTAL
Intervention: Sharpen filter
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3D Emboss filter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Original images
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Negative filter
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Shadow filter
Number of subjects: 40
Study: 24662901

Group type: EXPERIMENTAL
Intervention: Generalized joint hypermobility (JH)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control (non-JH)
Number of subjects: 272
Study: 21493292

Group type: EXPERIMENTAL
Intervention: Envoy Esteem Totally Implantable Hearing System
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (best-fit aided hearing aids)
Number of subjects: 57
Study: 19548437

Group type: EXPERIMENTAL
Intervention: Combined hormonotherapy with Chinese drugs for detoxifying
Number of subjects: 148

Group type: COMPARATOR
Intervention: Hormonotherapy alone
Number of subjects: 148
Study: 16426798

Group type: EXPERIMENTAL
Intervention: Haptotherapy treatment (5 sessions of 45 minutes each)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard medical care (control group)
Number of subjects: 31
Study: 14707013

Group type: EXPERIMENTAL
Intervention: High exercise level (Hex; approximately 4 MJ/day) with high-fat diet (HF; 50% of energy, 700 kJ/100 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High exercise level (Hex; approximately 4 MJ/day) with low-fat diet (LF; 20% of energy, 300 kJ/100 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No exercise (Nex; control) with high-fat diet (HF; 50% of energy, 700 kJ/100 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No exercise (Nex; control) with low-fat diet (LF; 20% of energy, 300 kJ/100 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-fat diet (HF; 50% of energy, 700 kJ/100 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF; 20% of energy, 300 kJ/100 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High exercise level (Hex; approximately 4 MJ/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No exercise (Nex; control)
Number of subjects: 8
Study: 11411815

Group type: EXPERIMENTAL
Intervention: Risperidone 4 mg/day
Number of subjects: 453

Group type: COMPARATOR
Intervention: Haloperidol 10 mg/day
Number of subjects: 453
Study: 9432096

Group type: EXPERIMENTAL
Intervention: 5% incline during min 5-15 (Run A)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 5% incline during min 20-30 (Run B)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (0% grade)
Number of subjects: 6
Study: 8518048

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 0
Study: 2830952

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (DHAD)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Cisplatin (DDP)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (DHAD) and Cisplatin (DDP)
Number of subjects: 69
Study: 31843251

Group type: EXPERIMENTAL
Intervention: Pharmacomechanical catheter-directed thrombolysis (PCDT)
Number of subjects: 691

Group type: COMPARATOR
Intervention: No pharmacomechanical catheter-directed thrombolysis (no PCDT)
Number of subjects: 691
Study: 28793785

Group type: EXPERIMENTAL
Intervention: Pictorial aid intervention (photographic representation of medications, indications, and dosing schedule)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard clinic visit discharge medication list (control)
Number of subjects: 46
Study: 26420825

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry (GAT) by two ophthalmologists (group 1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry (GAT) by two non-ophthalmologists (group 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry (GAT) by one ophthalmologist and one non-ophthalmologist (group 3)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dynamic contour tonometry (DCT) by two ophthalmologists (group 1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dynamic contour tonometry (DCT) by two non-ophthalmologists (group 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dynamic contour tonometry (DCT) by one ophthalmologist and one non-ophthalmologist (group 3)
Number of subjects: 100
Study: 24194508

Group type: EXPERIMENTAL
Intervention: Exenatide (10 μg four times a day)
Number of subjects: 14
Study: 22435658

Group type: EXPERIMENTAL
Intervention: Cow's milk allergy (CMA) group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Positive CM skin prick test (SPT)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: CMA group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Positive egg SPT
Number of subjects: 95
Study: 20578532

Group type: EXPERIMENTAL
Intervention: Live probiotic
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Killed probiotic
Number of subjects: 43
Study: 18829776

Group type: EXPERIMENTAL
Intervention: Whole-body hypothermia
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control
Number of subjects: 208
Study: 15929052

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 1 x 10(8) autologous MSCs (n = 5)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 30
Study: 11923805

Group type: EXPERIMENTAL
Intervention: Bisoprolol fumarate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 10102961

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 400 mg, metronidazole 500 mg, and clarithromycin 500 mg, all twice daily for 1 week (RMC)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Amoxycillin 1000 mg substituted for clarithromycin (RMA)
Number of subjects: 201
Study: 7572746

Group type: EXPERIMENTAL
Intervention: Soy formula with dephytinization
Number of subjects: 8

Group type: COMPARATOR
Intervention: Soy formula with native phytic acid
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Soy formula with ascorbic acid at 625 mumol/L (110 mg/L)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Soy formula with ascorbic acid at 1250 mumol/L (220 mg/L)
Number of subjects: 8
Study: 2405811

Group type: EXPERIMENTAL
Intervention: Isokinetic concentric training on a Cybex II+ isokinetic dynamometer, three days weekly for six weeks, five sets of ten maximal effort knee extensions at 1.05 rad/s
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study: 7441660

Group type: EXPERIMENTAL
Intervention: naproxen (750 mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: indomethacin (100 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 0
Study: 31773764

Group type: EXPERIMENTAL
Intervention: Integrated self-care intervention targeting adults with concomitant HF and T2D for 6 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Oral antiglycemic medication and insulin
Number of subjects: 180

Group type: COMPARATOR
Intervention: History of depression
Number of subjects: 180

Group type: COMPARATOR
Intervention: Cardiac pacemaker
Number of subjects: 180

Group type: COMPARATOR
Intervention: Digitalis
Number of subjects: 180
Study: 30907034

Group type: EXPERIMENTAL
Intervention: FMPBE (250 mg/day, n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (250 mg starch/day, n = 19)
Number of subjects: 40
Study: 29084159

Group type: EXPERIMENTAL
Intervention: Eating out frequency among females
Number of subjects: 4595

Group type: EXPERIMENTAL
Intervention: Reasons for eating out
Number of subjects: 4595

Group type: EXPERIMENTAL
Intervention: Favorite places for eating out
Number of subjects: 4595

Group type: EXPERIMENTAL
Intervention: Consideration of nutrition and food safety
Number of subjects: 4595

Group type: EXPERIMENTAL
Intervention: Demand for nutrition and food safety knowledge
Number of subjects: 4595

Group type: EXPERIMENTAL
Intervention: Association with monthly living expenses
Number of subjects: 4595
Study: 26030346

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate 80 mg/day
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate 160 mg/day
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate 240 mg/day
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 23769297

Group type: EXPERIMENTAL
Intervention: 15-month physical activity and dietary intervention
Number of subjects: 360
Study: 22484807

Group type: EXPERIMENTAL
Intervention: Circadian activity rhythm parameters (acrophase, amplitude, 24-h autocorrelation coefficient)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Circadian activity rhythm parameters in obese women
Number of subjects: 156
Study: 19836748

Group type: EXPERIMENTAL
Intervention: Flat patch mesh
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-dimensional mesh (plug)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double-sided patch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional studies
Number of subjects: 0
Study: 17691589

Group type: EXPERIMENTAL
Intervention: Fe-59 labeled iron(III)-hydroxide polymaltose complex (IPC, Maltofer), 100 mg elemental iron
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fe-59 labeled iron(III)-hydroxide polymaltose complex (IPC, Maltofer) combined with 600 mg aluminium hydroxide (10 ml)
Number of subjects: 22
Study: 15761783

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg bid)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg bid)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of N-acetylcysteine and Vitamin C (600 mg NAC and 500 mg Vitamin C bid)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine, Vitamin C, and NAC/Vitamin C combination
Number of subjects: 100
Study: 12847065

Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide (NT-proBNP)
Number of subjects: 6809

Group type: EXPERIMENTAL
Intervention: Combination of NT-proBNP and creatinine clearance
Number of subjects: 6809

Group type: EXPERIMENTAL
Intervention: Troponin T, creatinine clearance, and ST-segment depression
Number of subjects: 6809
Study: 10421142

Group type: EXPERIMENTAL
Intervention: 1.5 g of sulbactam plus ampicillin (group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2 g of cefazolin (group 2)
Number of subjects: 120
Study: 8889287

Group type: EXPERIMENTAL
Intervention: L-Dopa
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (neuroleptic drugs)
Number of subjects: 12
Study: 1987786

Group type: EXPERIMENTAL
Intervention: Intraoperative blood temperature of 28 degrees C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intraoperative blood temperature of 20 degrees C
Number of subjects: 20
Study: 7072873

Group type: EXPERIMENTAL
Intervention: Memory aids
Number of subjects: 1200
Study: 30921241

Group type: EXPERIMENTAL
Intervention: Propofol-based total intravenous anesthesia (TIVA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Desflurane anesthesia (DES)
Number of subjects: 60
Study: 27614769

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 IU)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 26427987

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with combined application of MMC (0.4 mg/ml for 3 min) and bevacizumab (2.5 mg in 0.2 ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trabeculectomy with application of MMC (0.4 mg/ml for 3 min) only
Number of subjects: 12